Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

被引:92
作者
Oda, MN
Bielicki, JK
Ho, TT
Berger, T
Rubin, EM
Forte, TM
机构
[1] Lawrence Berkeley Natl Lab, Life Sci Div MS 1 220, Berkeley, CA 94720 USA
[2] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA
关键词
paraoxonase; transgenic mice; lipid peroxidation; lecithin : cholesterol acyltransferase; highdensity lipoproteins;
D O I
10.1006/bbrc.2001.6295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated enzyme believed to protect against the early events of atherogenesis by its ability to hydrolyze oxidized phospholipids. A transgenic mouse overexpressing PON1 (mPON1) was developed to address the question of whether overexpression of PON1 is important in protecting HDL function during oxidative stress. Transgenic mice were obtained that have up to a 5-fold increase in mPON1 activity measured as arylesterase activity [52.7 +/- 17.3 U/ml versus 251.7 +/- 25.1 U/ml for wild-type (WT) and mPON1 high expressers, respectively]; this increase in mPON1 activity was reflected by a 5.3-fold increase in relative mass of the enzyme. Excess mPON1 was associated solely with HDL but did not alter HDL composition, size, or charge. Lecithin:cholesterol acyltransferase (LCAT) on HDL is a sensitive indicator of oxidative stress; exposure of plasmas from both WT and mPON1 overexpresser mice to 0.4 mM copper ions for 2 h showed a 30-40% protection of LCAT activity in mPON1 overexpressers compared to WT. Excess mPON1 also inhibited lipid hydroperoxide formation on HDL. These data strongly suggest that overexpression of mPON1 protects HDL integrity and function. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:921 / 927
页数:7
相关论文
共 30 条
[1]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[2]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[3]  
Bielicki JK, 1999, J LIPID RES, V40, P948
[4]  
Bielicki JK, 1996, J LIPID RES, V37, P1012
[5]  
BIELICKI JK, 1995, J LIPID RES, V36, P322
[6]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[7]   The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines [J].
Bortnick, AE ;
Rothblat, GH ;
Stoudt, G ;
Hoppe, KL ;
Royer, LJ ;
McNeish, J ;
Francone, OL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28634-28640
[8]   HIGH-DENSITY-LIPOPROTEIN IS THE MAJOR CARRIER OF LIPID HYDROPEROXIDES IN HUMAN BLOOD-PLASMA FROM FASTING DONORS [J].
BOWRY, VW ;
STANLEY, KK ;
STOCKER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10316-10320
[9]   Overexpression of apolipoprotein all in transgenic mice converts high density lipoproteins to proinflammatory particles [J].
Castellani, LW ;
Navab, M ;
VanLenten, BJ ;
Hedrick, CC ;
Hama, SY ;
Goto, AM ;
Fogelman, AM ;
Lusis, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) :464-474
[10]  
CHEN CH, 1982, J LIPID RES, V23, P680